0001390478-16-000111.txt : 20160607 0001390478-16-000111.hdr.sgml : 20160607 20160607183624 ACCESSION NUMBER: 0001390478-16-000111 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160601 FILED AS OF DATE: 20160607 DATE AS OF CHANGE: 20160607 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Galena Biopharma, Inc. CENTRAL INDEX KEY: 0001390478 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4640 SW MACADAM AVENUE STREET 2: SUITE 270 CITY: PORTLAND STATE: OR ZIP: 97239 BUSINESS PHONE: 855 855 GALE MAIL ADDRESS: STREET 1: 4640 SW MACADAM AVENUE STREET 2: SUITE 270 CITY: PORTLAND STATE: OR ZIP: 97239 FORMER COMPANY: FORMER CONFORMED NAME: RXi Pharmaceuticals Corp DATE OF NAME CHANGE: 20110926 FORMER COMPANY: FORMER CONFORMED NAME: GALENA BIOPHARMA, INC. DATE OF NAME CHANGE: 20110922 FORMER COMPANY: FORMER CONFORMED NAME: RXI PHARMACEUTICALS CORP DATE OF NAME CHANGE: 20110921 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dunlap Ryan CENTRAL INDEX KEY: 0001554742 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33958 FILM NUMBER: 161702358 MAIL ADDRESS: STREET 1: 310 N. STATE STREET, SUITE 208 CITY: LAKE OSWEGO STATE: OR ZIP: 97034 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2016-06-01 1 0001390478 Galena Biopharma, Inc. GALE 0001554742 Dunlap Ryan C/O GALENA BIOPHARMA, INC. 2000 CROW CANYON PL., SUITE 380 SAN RAMON CA 94583 0 1 0 0 Former Chief Financial Officer Common Stock 2016-06-01 4 M 0 31250 1.75 A 49952 D Common Stock 2016-06-01 4 M 0 65625 1.85 A 115577 D Common Stock 2016-06-01 4 M 0 30000 1.71 A 145577 D Common Stock 2016-06-01 4 S 0 126875 2.18 D 18702 D Stock Option 1.75 2016-06-01 4 M 0 31250 0 D Common Stock 31250 95625 D Stock Option 1.85 2016-06-01 4 M 0 65625 0 D Common Stock 65625 30000 D Stock Option 1.71 2016-06-01 4 M 0 30000 0 D Common Stock 30000 0 D The Price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.16 to $2.22 per share. The reporting person undertakes the provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The trades settled on June 6, 2016. The option vests on a quarterly basis over four years, commencing on the last day of the quarter after the date of grant (1/15/15). This stock option was subject to cancellation on June 29, 2016, which was 90 days after the Reporting person's consulting agreement ended with the Issuer. The option vests on a quarterly basis over four years, commencing on the last day of the quarter after the date of grant (7/9/12). The option vests on a quarterly basis over four years, commencing on the last day of the quarter after the date of grant (1/29/13). Ryan M. Dunlap 2016-06-07